chr2-190482584-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_017694.4(MFSD6):c.1631-6073G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 151,770 control chromosomes in the GnomAD database, including 7,492 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.30 ( 7492 hom., cov: 30)
Consequence
MFSD6
NM_017694.4 intron
NM_017694.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.00100
Publications
8 publications found
Genes affected
MFSD6 (HGNC:24711): (major facilitator superfamily domain containing 6) Predicted to enable MHC class I protein binding activity and MHC class I receptor activity. Predicted to be involved in antigen processing and presentation of exogenous peptide antigen via MHC class I. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
NEMP2 (HGNC:33700): (nuclear envelope integral membrane protein 2) Predicted to be located in nuclear inner membrane. Predicted to be integral component of membrane. Predicted to be active in nuclear envelope. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.45 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MFSD6 | ENST00000392328.6 | c.1631-6073G>T | intron_variant | Intron 4 of 7 | 2 | NM_017694.4 | ENSP00000376141.1 | |||
MFSD6 | ENST00000281416.11 | c.1631-6073G>T | intron_variant | Intron 2 of 5 | 1 | ENSP00000281416.7 | ||||
MFSD6 | ENST00000434582.5 | c.236-6073G>T | intron_variant | Intron 2 of 6 | 5 | ENSP00000397276.1 | ||||
MFSD6 | ENST00000444317.1 | c.17-6073G>T | intron_variant | Intron 2 of 4 | 4 | ENSP00000406837.1 |
Frequencies
GnomAD3 genomes AF: 0.298 AC: 45234AN: 151652Hom.: 7479 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
45234
AN:
151652
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.298 AC: 45275AN: 151770Hom.: 7492 Cov.: 30 AF XY: 0.311 AC XY: 23030AN XY: 74160 show subpopulations
GnomAD4 genome
AF:
AC:
45275
AN:
151770
Hom.:
Cov.:
30
AF XY:
AC XY:
23030
AN XY:
74160
show subpopulations
African (AFR)
AF:
AC:
11162
AN:
41360
American (AMR)
AF:
AC:
7013
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1017
AN:
3468
East Asian (EAS)
AF:
AC:
2381
AN:
5140
South Asian (SAS)
AF:
AC:
1061
AN:
4808
European-Finnish (FIN)
AF:
AC:
4470
AN:
10480
Middle Eastern (MID)
AF:
AC:
71
AN:
292
European-Non Finnish (NFE)
AF:
AC:
17305
AN:
67930
Other (OTH)
AF:
AC:
590
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1505
3010
4516
6021
7526
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1150
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.